P166: Prognostic significance of eosinophil granule proteins in inflammatory bowel diseaseECCO '18 Vienna
2018
P167: Long-term outcomes of cyclosporine A and infliximab treatment for the management of steroid-refractory acute severe ulcerative colitisECCO '18 Vienna
2018
P168: Predicting outcome in acute severe ulcerative colitis: Comparison of the Oxford, Edinburgh, Lindgren and endoscopic Mayo scoresECCO '18 Vienna
2018
P169: Infliximab trough levels after induction therapy are predictive for infliximab efficacy in paediatric patients with inflammatory bowel diseaseECCO '18 Vienna
2018
P170: Azathioprine metabolite (6-TGN) levels within a defined therapeutic range are associated with lower faecal calprotectin in Crohn’s diseaseECCO '18 Vienna
2018
P171: A multi-marker serum test predicts mucosal healing status in Crohn’s disease regardless of disease locationECCO '18 Vienna
2018
P172: Histological healing is associated with decreased clinical relapse in patients with ileal Crohn’s diseaseECCO '18 Vienna
2018
P173: Danese’s “Red flag Instrument” for early Crohn’s disease referral may also pick up ulcerative colitis patients – a prospective studyECCO '18 Vienna
2018
P175: Fatigue and its severity depends on demographic and clinical factors in the Polish population of patients with inflammatory bowel disease - results of a cross-sectional studyECCO '18 Vienna
2018
P176: Improving quality of care through patient´s eyes: Results from IQCARO project focus groupsECCO '18 Vienna
2018
P177: Prognostic factors for colectomy and acute severe colitis in paediatric ulcerative colitis: A systematic reviewECCO '18 Vienna
2018
P178: Sleep fragmentation measured by wearable device is an indicator of clinical disease activity in inflammatory bowel diseaseECCO '18 Vienna
2018
P179: Visceral fat hypertrophy does not have an impact on the activity and severity of Crohn’s diseaseECCO '18 Vienna
2018
P180: Role of hydrosonography of small bowel in the detection of inflammatory bowel diseaseECCO '18 Vienna
2018
P181: A retrospective analysis of the clinical application of the multigene analysis test DiBiCol® to differentiate between ulcerative colitis and Crohn’s disease and Non-IBDECCO '18 Vienna
2018
P182: Intestinal diffuse neuroendocrine system and proliferation indicators in prediction of non-specific ulcerative colitis occurrence and courseECCO '18 Vienna
2018